Bicycle Therapeutics (BCYC) Exchange Rate Effect (2018 - 2026)
Bicycle Therapeutics (BCYC) reported Exchange Rate Effect of -$1.9 million for Q1 2026, down 515.38% on a YoY basis from $468000.0 in Q1 2025, and down 775.68% quarter-over-quarter from -$222000.0 in Q4 2025.
Bicycle Therapeutics (BCYC) Exchange Rate Effect (2018 - 2026) Analysis & Trends
Bicycle Therapeutics has reported Exchange Rate Effect for 9 years, with the latest figure at -$1.9 million in Q1 2026.
- For the quarter ending Q1 2026, Exchange Rate Effect fell 515.38% year-over-year to -$1.9 million; the trailing twelve-month figure through Mar 2026 stood at -$1.6 million (down 946.32% YoY), and the FY2025 full-year result was $804000.0, up 215.85% from the prior year.
- Exchange Rate Effect for Q1 2026 stood at -$1.9 million, down from -$222000.0 in the prior quarter.
- The five-year high for Exchange Rate Effect was $3.6 million in Q4 2022, with the low at -$2.6 million in Q3 2022.
- Historically, Exchange Rate Effect has averaged -$94588.2 across 5 years, with a median of -$222000.0 in 2025.
- The largest YoY upside for Exchange Rate Effect was 59333.33% in 2022 against a maximum downside of 743.1% in 2022.
- Bicycle Therapeutics' Exchange Rate Effect stood at $3.6 million in 2022, then plunged by 63.73% to $1.3 million in 2023, then plunged by 238.17% to -$1.8 million in 2024, then surged by 87.54% to -$222000.0 in 2025, then tumbled by 775.68% to -$1.9 million in 2026.
- The last three Exchange Rate Effect figures came in at -$1.9 million (Q1 2026), -$222000.0 (Q4 2025), and -$1.2 million (Q3 2025), per Business Quant data.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Exchange Rate Effect (Qtr) |
|---|---|---|---|---|---|
| 1 | Alterity Therapeutics | 925,601.88 Bn | 925,601.85 Bn | - | - |
| 2 | Belite Bio | 58,560.00 Bn | 58,560.00 Bn | - | - |
| 3 | Quantum Biopharma | 17,284.41 Bn | 17,284.40 Bn | - | 3.60 Mn |
| 4 | Legend Biotech | 2,809.00 Bn | 2,808.71 Bn | 242.10 Mn | -2.70 Mn |
| 5 | Evaxion A | 1,334.43 Bn | 1,334.42 Bn | - | - |
| 6 | Akari Therapeutics | 1,312.27 Bn | 1,312.26 Bn | - | - |
| 7 | Psyence Biomedical | 212.16 Bn | 212.16 Bn | - | - |
| 8 | Vertex Pharmaceuticals | 114.83 Bn | 107.58 Bn | 2.59 Bn | -40.30 Mn |
| 9 | Abivax | 91.96 Bn | 91.96 Bn | - | 8.68 Mn |
| 10 | Bicycle Therapeutics | 278.04 Mn | 278.04 Mn | - | -1.94 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -1.94 Mn |
| Mar 31, 2026 | -1.94 Mn |
| Dec 31, 2025 | -222,000.00 |
| Dec 31, 2025 | -222,000.00 |
| Sep 30, 2025 | -1.25 Mn |
| Sep 30, 2025 | -1.25 Mn |
| Jun 30, 2025 | 1.81 Mn |
| Jun 30, 2025 | 1.81 Mn |
| Mar 31, 2025 | 468,000.00 |
| Mar 31, 2025 | 468,000.00 |
| Dec 31, 2024 | -1.78 Mn |
| Dec 31, 2024 | -1.78 Mn |
| Sep 30, 2024 | 1.70 Mn |
| Sep 30, 2024 | 1.70 Mn |
| Jun 30, 2024 | -192,000.00 |
| Jun 30, 2024 | -192,000.00 |
| Mar 31, 2024 | -416,000.00 |
| Mar 31, 2024 | -416,000.00 |
| Dec 31, 2023 | 1.29 Mn |
| Dec 31, 2023 | 1.29 Mn |